Invuity to Present at William Blair Annual Growth Stock Conference
Get Alerts IVTY Hot Sheet
Join SI Premium – FREE
SAN FRANCISCO, May 29, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to present at the 38th Annual Growth Stock Conference on Tuesday, June 12, 2018 at 9:30 a.m. Central Time in Chicago.
A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation.
About Invuity®Invuity, Inc. is a leading medical technology company focused on developing and marketing advanced surgical devices to improve the ability of physicians to perform minimal access surgery through smaller and hidden incisions. The Company’s patented Intelligent Photonics® technology delivers enhanced visualization, which facilitates surgical precision, efficiency and safety. Clinical applications include women’s health, encompassing breast cancer and breast reconstruction surgery, gynecology and thyroid surgery. Additional applications include procedures for electrophysiology, spine, orthopedic, cardiothoracic and general surgery. Invuity is headquartered in San Francisco, CA.
CONTACT:Company Contact:Jim MackanessChief Financial OfficerInvuity, Inc.415-655-2129
Investors:Mark KlausnerWestwicke Partners443-213-0501[email protected]
Source: Invuity, Inc.Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Starts Surrozen Inc. (SRZN) at Outperform
- Kairos Pharma Announces 1-for-7 Reverse Stock Split
- Employment Inducement Grants under Nasdaq Listing Rules
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share